Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea

BACKGROUND/AIMS: To evaluate drug survival of the tumor necrosis factor α inhibitors (TNFi) and risk factors for the drug discontinuation in patients with ankylosing spondylitis (AS). METHODS: We retrospectively evaluated 487 AS patients at a single tertiary hospital. Among the TNFi users, drug surv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Korean J Intern Med
Autores principales: Jeong, Hyemin, Eun, Yeong Hee, Kim, In Young, Kim, Hyungjin, Ahn, Joong Kyong, Lee, Jaejoon, Koh, Eun-Mi, Cha, Hoon-Suk
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5840589/
https://ncbi.nlm.nih.gov/pubmed/27729625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.042
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares